Prescription Now Mandatory for Cough Syrups and Other Syrup Medicines in India

The Union Ministry of Health and Family Welfare has introduced a significant regulatory change that will affect how syrup-based medicines are sold across India.

Under the newly notified Drugs (Fifth Amendment) Rules, 2026, consumers will no longer be able to purchase syrup medicines, including cough syrups, over the counter. A doctor's prescription will now be required to buy these medicines.

The amendment was officially notified in the Gazette of India on June 9, 2026.

Why Has the Government Taken This Step?

The move stems from an amendment to the Drugs Rules, 1945. Specifically, the government has removed the word "Syrups" from item number (7) under serial number 13 of Schedule K.

Schedule K contains categories of medicines that are exempt from certain provisions of Chapter IV of the Drugs and Cosmetics Act, 1940, subject to specific conditions. By removing syrups from this list, the government has effectively ended a regulatory exemption that previously allowed their sale under less stringent conditions.

As a result, syrup medicines will now be subject to the applicable regulatory requirements governing their sale and distribution.

What Does Schedule K Mean?

Schedule K is a provision within the Drugs Rules, 1945, that identifies certain categories of medicines exempt from specific regulatory requirements.

Until now, syrups were included among the exempted categories. Their removal means these medicines will now be regulated more strictly, bringing their sale closer in line with other prescription-based drugs.

What Does the Official Notification Say?

The notification states: “Now, therefore, in exercise of the powers conferred by sections 12 and 33 of the said Act, the Central Government, after consultation with the Drugs Technical Advisory Board, hereby makes the following rules further to amend the Drugs Rules, 1945, namely.”

The amendment further reads: “In the Drugs Rules, 1945, in Schedule K, in the column, under the heading Class of Drugs, against serial number 13, in item number (7), the word 'Syrups,' shall be omitted.”

Was Public Feedback Considered?

Yes. Before finalising the amendment, the Centre had issued a draft notification on December 29, 2025, inviting objections and suggestions from stakeholders and members of the public.

According to the government, all comments received on the draft rules were examined before the final notification was issued.

Who Approved the Change?

The notification was issued after consultation with the Drugs Technical Advisory Board, the government's key technical body for matters related to drug regulation and standards.

What Does This Mean for Consumers?

For consumers, the most immediate impact is that syrup medicines, including commonly used cough syrups, can no longer be purchased freely from pharmacies. Buyers will now have to obtain a valid prescription from a registered medical practitioner before purchasing such medicines.

The government says the change is part of the broader regulatory framework governing the manufacture, sale and distribution of medicines under the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.

(With inputs from ANI)